SAB Biotherapeutics, Inc. (NASDAQ:SABSW) Short Interest Down 98.1% in October

SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Free Report) saw a significant decline in short interest in October. As of October 31st, there was short interest totalling 100 shares, a decline of 98.1% from the October 15th total of 5,200 shares. Based on an average daily volume of 13,200 shares, the short-interest ratio is presently 0.0 […]

Leave a Reply

Your email address will not be published.

Previous post CureVac (NASDAQ:CVAC) Shares Gap Up – Still a Buy?
Next post Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Down 82.9% in October